Association in Facial Phenotype, Gene, Disease: A Dataset for Explainable Rare Genetic Diseases Diagnosis
Authors:
Jie Song,
Mengqiao He,
Shumin Ren,
Bairong Shen
Abstract:
Many rare genetic diseases exhibit recognizable facial phenotypes, which are often used as diagnostic clues. However, current facial phenotype diagnostic models, which are trained on image datasets, have high accuracy but often suffer from an inability to explain their predictions, which reduces physicians' confidence in the model output.In this paper, we constructed a dataset, called FGDD, which…
▽ More
Many rare genetic diseases exhibit recognizable facial phenotypes, which are often used as diagnostic clues. However, current facial phenotype diagnostic models, which are trained on image datasets, have high accuracy but often suffer from an inability to explain their predictions, which reduces physicians' confidence in the model output.In this paper, we constructed a dataset, called FGDD, which was collected from 509 publications and contains 1147 data records, in which each data record represents a patient group and contains patient information, variation information, and facial phenotype information. To verify the availability of the dataset, we evaluated the performance of commonly used classification algorithms on the dataset and analyzed the explainability from global and local perspectives. FGDD aims to support the training of disease diagnostic models, provide explainable results, and increase physicians' confidence with solid evidence. It also allows us to explore the complex relationship between genes, diseases, and facial phenotypes, to gain a deeper understanding of the pathogenesis and clinical manifestations of rare genetic diseases.
△ Less
Submitted 25 March, 2025;
originally announced March 2025.
Sex Differences in Severity and Mortality Among Patients With COVID-19: Evidence from Pooled Literature Analysis and Insights from Integrated Bioinformatic Analysis
Authors:
Xiyi Wei,
Yu-Tian Xiao,
Jian Wang,
Rui Chen,
Wei Zhang,
Yue Yang,
Daojun Lv,
Chao Qin,
Di Gu,
Bo Zhang,
Weidong Chen,
Jianquan Hou,
Ninghong Song,
Guohua Zeng,
Shancheng Ren
Abstract:
Objective: To conduct a meta-analysis of current studies that examined sex differences in severity and mortality in patients with COVID-19, and identify potential mechanisms underpinning these differences. Methods: We performed a systematic review to collate data from observational studies examining associations of sex differences with clinical outcomes of COVID-19. PubMed, Web of Science and four…
▽ More
Objective: To conduct a meta-analysis of current studies that examined sex differences in severity and mortality in patients with COVID-19, and identify potential mechanisms underpinning these differences. Methods: We performed a systematic review to collate data from observational studies examining associations of sex differences with clinical outcomes of COVID-19. PubMed, Web of Science and four preprint servers were searched for relevant studies. Data were extracted and analyzed using meta-analysis where possible, with summary data presented otherwise. Publicly available bulk RNA sequencing (RNA-seq), single-cell RNA sequencing (scRNA-seq), and chromatin immunoprecipitation sequencing (ChIP-seq) data were analyzed to explore the potential mechanisms underlying the observed association. Results: 39 studies met inclusion criteria, representing 77932 patients, of which 41510 (53.3%) were males. Men were at a markedly increased risk of developing severe cases compared with women. Furthermore, the pooled odds ratio (OR) of mortality for male group compared with the female group indicated significant higher mortality rate for male. Data from scRNA-seq suggest that men have a higher amount of ACE2-expressing pulmonary alveolar type II cells than women. Sex-based immunological differences exist. The expression of androgen receptor (AR) is positively correlated with ACE2, and there is evidence that AR may directly regulate the expression of ACE2. Conclusions: This meta-analysis detected an increased severity and mortality rate in the male populations with COVID-19, which might be attributable to the sex-based differences in cellular compositions and immunological microenvironments of the lung. The host cell receptor ACE2 is likely regulated by AR signaling pathway, which is identified as a potential target for prevention and treatment of SARS-Cov-2 infections in men.
△ Less
Submitted 30 March, 2020;
originally announced March 2020.
